Role of NLRP6 in Chronic Periodontitis
Evaluation of Serum NLRP6 in Chronic Periodontitis Patients
1 other identifier
observational
50
1 country
1
Brief Summary
The quantification of NLRP6 in blood samples will be analyzed from individuals with chronic periodontitis but without systemic disease. Demographic and periodontal parameters will be assessed and correlated with the NLRP6 quantification using RT-PCR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2024
CompletedFirst Posted
Study publicly available on registry
May 6, 2024
CompletedStudy Start
First participant enrolled
December 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 22, 2025
CompletedNovember 24, 2025
April 1, 2025
3 months
April 30, 2024
November 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quantification of NLRP6 gen, Quantification of NLRP6 gen using RT-PCR
12 months
Interventions
intervention: Evaluation of serum NLRP6 levels control: Evaluation of serum NLRP6 levels
Eligibility Criteria
Patients referred to the periodontology department of the University School of Dentistry Medical sciences of Babol
You may qualify if:
- Age: At least 25 years old
- Clinical diagnosis of chronic periodontitis
- At least 15 teeth in the mouth
You may not qualify if:
- premalignant lesions and cancer of the oral cavity
- periodontal treatment in the last 6 months
- systemic disorders affecting the periodontal condition (autoimmunity and endocrine disorders)
- diabetes mellitus and rheumatoid arthritis
- pregnancy or breastfeeding
- taking drugs with the possibility of affecting the periodontal condition (calcium channel blockers, anticonvulsants, etc.)
- Smoking
- aggressive PD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dental School, Periodontology Department
Babol, Iran
Biospecimen
Blood samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Morteza Rabbani, DS
Study Record Dates
First Submitted
April 30, 2024
First Posted
May 6, 2024
Study Start
December 13, 2024
Primary Completion
February 28, 2025
Study Completion
November 22, 2025
Last Updated
November 24, 2025
Record last verified: 2025-04